You are here: Industry Insights > N501Y

News List

Omixon, SeqOnce Announce Extension to AzureSeq-200 Assay to Detect SARS-CoV-2 N501Y Variant americanpharmaceuticalreview
February 01, 2021
Omixon and SeqOnce Biosciences announce the launch of a new extension to the AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 N501Y variant.
Study suggests Pfizer/BioNTech vaccine effective against Covid-19 variants pharmaceutical-technology
January 11, 2021
New research suggests that Pfizer/BioNTech’s mRNA Covid-19 vaccine, BNT162b2, protects against two variants of SARS-CoV-2, the virus that causes Covid-19, that have emerged in the UK and South Africa.
Scientists say UK strain unlikely to affect efficacy of COVID-19 vaccines, warn against more mutations expresspharma
December 24, 2020
The faster spreading coronavirus strain first detected in the UK is unlikely to make vaccines less effective as of now but the preventives may need to be appropriately altered if more mutations occur over time, say scientists.